Last deal

$3M

Amount

Post-IPO Equity

Stage

28.11.2018

Date

7

all rounds

$97.8M

Total amount

General

About Company
Osprey Medical is a medical device company that develops and commercializes the CINCOR System.

Industry

Sector :

Subsector :

Keywords :

Also Known As

V- Kardia

founded date

01.01.2005

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Osprey Medical focuses on protecting patients from the harmful effects of contrast dye used in angiographic imaging procedures. Their proprietary technologies, such as DyeVert Plus EZ and DyeVert Plus, decrease the amount of dye injected without compromising image quality, leading to more efficient and effective procedures and a significant reduction in the risk of acute kidney injury.
Contacts

Social url